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A B S T R A C T
Imbalances in the oral microbial community have been associated with reduced cardiovascular and metabolic
health. A possible mechanism linking the oral microbiota to health is the nitrate (NO3-)-nitrite (NO2-)-nitric
oxide (NO) pathway, which relies on oral bacteria to reduce NO3- to NO2-. NO (generated from both NO2- and L-
arginine) regulates vascular endothelial function and therefore blood pressure (BP). By sequencing bacterial 16S
rRNA genes we examined the relationships between the oral microbiome and physiological indices of NO
bioavailability and possible changes in these variables following 10 days of NO3- (12mmol/d) and placebo
supplementation in young (18–22 yrs) and old (70–79 yrs) normotensive humans (n=18). NO3- supplementa-
tion altered the salivary microbiome compared to placebo by increasing the relative abundance of Proteobacteria
(+225%) and decreasing the relative abundance of Bacteroidetes (−46%; P < 0.05). After
NO3-supplementation the relative abundances of Rothia (+127%) and Neisseria (+351%) were greater, and
Prevotella (−60%) and Veillonella (−65%) were lower than in the placebo condition (all P < 0.05). NO3-
supplementation increased plasma concentration of NO2- and reduced systemic blood pressure in old
(70–79 yrs), but not young (18–22 yrs), participants. High abundances of Rothia and Neisseria and low abun-
dances of Prevotella and Veillonella were correlated with greater increases in plasma [NO2-] in response to NO3-
supplementation. The current ﬁndings indicate that the oral microbiome is malleable to change with increased
dietary intake of inorganic NO3-, and that diet-induced changes in the oral microbial community are related to
indices of NO homeostasis and vascular health in vivo.
1. Introduction
Inorganic nitrate (NO3-) is a natural part of the human diet that is
found in high concentrations in many vegetables. NO3- itself is biolo-
gically inert and human cells are believed to lack NO3--reductase cap-
ability. However, commensal bacteria in the oral cavity can use nitrate
as a terminal electron acceptor for ATP synthesis, reducing NO3- to
nitrite (NO2-; which can be vasoactive in low-oxygen and low-pH
conditions) and this NO2- can be further reduced to the potent vaso-
dilator, nitric oxide (NO) [9]. The NO3-- NO2--NO reduction pathway
underpins the discovery that dietary NO3- supplementation through
consumption of NO3- salts [27] or vegetable products such as beetroot
juice [23,40] reduces blood pressure (BP) in healthy young and old
humans.
The importance of a functional oral microbiome for the NO3-- NO2--
NO reduction pathway is highlighted in cases where use of antibacterial
mouthwash markedly blunts the increase in plasma and saliva NO2-
concentrations and associated decrease in BP following ingestion of a
standardised NO3- dose [14,22,31]. Epidemiological studies also in-
dicate that dysbiosis of the oral microbial community is associated with
poor cardiovascular health [5]. Conversely, a diet rich in vegetables,
which contain high concentrations of inorganic NO3-, signiﬁcantly
protects against both coronary heart disease and stroke [16,2,20].
Ageing has been associated with reduced salivary ﬂow rate (‘dry
mouth’) and altered oral bacterial colonisation [33,42], but it is not
known whether the abundances of NO3- reducing oral bacteria decline
with age. Dietary NO3- intake, and the abundance of NO3--reducing oral
bacteria, therefore represent routes to lower blood pressure and main-
tain and improve cardiovascular health across the human lifespan.
It is possible that dietary NO3- as a prebiotic treatment might
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promote proliferation of NO3- reducing bacteria. In a rodent model, a
NO3--rich diet over 7 days increased abundance of oral bacteria
(Streptococcus and Haemophilus) that contain NO3- reductase genes [17].
In saliva samples of hypercholesterolaemic humans, 6 weeks of NO3-
supplementation with beetroot juice signiﬁcantly increased the abun-
dance of Neisseria ﬂavescens and tended to increase Rothia mucilaginosa
which are known NO3- reducers [39]. These studies indicate that in-
creased dietary NO3- intake may alter the oral microbiome in a way
which enhances an individual's ability to reduce ingested NO3-, re-
sulting in greater plasma NO2- concentration and a greater reduction in
systemic blood pressure. However, characterisation of potential
changes in the oral microbiome of healthy young and old humans in
response to NO3- supplementation is lacking.
In the present study, we used 16S rRNA gene sequencing to in-
vestigate whether abundances of NO3--reducing bacteria on the surface
of the human tongue modulate an individual's response to NO3- sup-
plementation in young (18–22 years) and old (70–79 years) normo-
tensive adults. We hypothesised that at baseline, abundances of known
NO3--reducing bacteria (including Neisseria, Prevotella, Rothia,
Veillonella and Actinomycetales) would be greater in young compared
to old participants, and that high abundances of these bacteria at
baseline would be associated with higher plasma NO2- concentrations,
and greater changes in blood pressure and arterial stiﬀness in response
to NO3- supplementation. We also investigated whether 10 days of
regular dietary NO3- ingestion altered the oral microbiome compared
with placebo supplementation. It was hypothesised that oral micro-
biomes would be diﬀerent between placebo and NO3- conditions, and
speciﬁcally that the relative abundances of bacteria capable of NO3-




The study was approved by the institutional Ethics Committee
(Sport and Health Sciences, University of Exeter) and conducted in
accordance with the code of the ethical principles of the World Medical
Association (Declaration of Helsinki). All participants gave their written,
informed consent before the commencement of the study, once the
experimental procedures, associated risks, and potential beneﬁts of
participation had been explained.
2.2. Study participants
Nine old adults including six females (mean± SD, age 75 ± 3 yrs,
age range 70–79 yrs, height 162 ± 6 cm, body mass 61.8 ± 14.0 kg)
and three males (age 73 ± 5 yrs, age range 70–78 yrs, height
172 ± 4 cm, body mass 77.7 ± 11.6 kg) and nine young adults in-
cluding ﬁve females (age 20 ± 1 yrs, age range 19–22 yrs, height
168 ± 7 cm, body mass 67.9 ± 10.3 kg) and four males (age
20 ± 2 yrs, age range 18–22 yrs, height 180 ± 4 cm, body mass
73.4 ± 12.9 kg) volunteered to participate in this study (Table 1). All
participants were of Caucasian ethnicity. The nine old adults re-
presented a subsample of a larger cohort tested for a Dunhill Medical
Trust funded project (R269/1112) from which the microbiome of the
tongue and saliva were retrospectively analysed. Participants were
screened prior to participation to ensure suitability for the study. All
participants were ostensibly healthy and were not taking medication or
dietary supplements. None of the participants were tobacco smokers
and all reported having no oral diseases. Participants were instructed to
arrive at the laboratory in a rested and fully hydrated state, at least 3 h
postprandial, and to avoid strenuous physical exertion in the 24 h
preceding each laboratory visit. Participants were also asked to refrain
from caﬀeine and alcohol intake 6 and 24 h before each test, respec-
tively. All tests were performed at approximately the same time of day
( ± 2 h) for each participant.
2.3. Experimental design
Prior to commencing dietary supplementation, participants visited
the laboratory for health screening and familiarisation to test protocols.
Participants completed a salivary ﬂow rate questionnaire (SFR-Q; [11]).
The SFR-Q included eleven questions which asked the participant to
rate the frequency of various symptoms of low salivary ﬂow rate on a
scale of 1 (‘never’) to 5 (‘very often’). Participants then underwent two
10-day dietary supplementation periods with NO3- and placebo in a
randomised, double-blind, cross-over design (Fig. 1). On days 8, 9 and
10 of each supplementation period, participants returned to the la-
boratory. Upon arrival at the laboratory on days 8, 9 and 10 venous
blood samples were collected for the measurement of plasma [NO2-]
and [NO3-] and resting BP was measured. The mean values of three
measurements of [NO2-], [NO3-] and BP were used for further analyses.
Saliva samples were also collected on each visit and these three samples
were pooled for analysis of the salivary microbiome. Arterial stiﬀness
was assessed on one occasion (day 8, 9 or 10) using radial-femoral pulse
wave velocity (PWV).
2.4. Supplementation
The supplements were NO3- -rich concentrated beetroot juice (BR)
Table 1
Participant characteristics, nitrate (NO3-) dose and plasma [NO2-] responsive-
ness to supplementation, and salivary ﬂow rate questionnaire (SFR-Q) results.
The young and old participants were similar in terms of body mass and BMI.
The NO3- dose was similar in both groups but old participants had a greater
increase than the young in plasma [NO2-] in response to supplementation. The
young reported feeling more frequent symptoms of low salivary ﬂow rate than
the old participants.

















1 F 77 88.0 33.1 0.14 7543 1.2
2 F 79 66.2 22.1 0.19 2325 1.3
3 F 70 60.0 24.3 0.21 2962 1.7
4 F 76 53.1 20.7 0.23 3942 1.1
5 F 72 51.4 20.1 0.24 4819 1.7
6 F 74 52.3 20.2 0.24 5428 1.9
7 M 78 88.8 31.1 0.14 812 2.0
8 M 70 78.6 25.4 0.16 5461 1.0
9 M 70 65.6 22.7 0.19 4829 1.5
Mean 74.0 67.1 24.4 0.19 4236 1.4
SD 3.6 14.8 4.7 0.04 1988 0.4
YOUNG
10 F 22 71.5 29.4 0.17 803 1.9
11 F 19 60.8 22.9 0.20 2202 2.5
12 F 19 64.5 22.6 0.19 880 1.6
13 F 20 69.7 24.4 0.18 1604 2.7
14 F 19 85.2 28.5 0.15 999 1.5
15 M 18 55.7 18.0 0.22 2371 1.5
16 M 22 81.2 23.7 0.15 3254 1.6
17 M 19 72.3 22.3 0.17 1127 2.1
18 M 19 84.4 26.0 0.15 70 2.1
Mean 19.7* 71.7 24.2 0.18 1479* 2.0*
SD 1.4 10.4 3.5 0.03 977 0.4
OVERALL (OLD + YOUNG)
Mean 46.8 69.4 24.3 0.18 2857 1.7
SD 28.1 12.6 4.0 0.03 2079 0.5
F, female; M, male; BMI, body mass index; Δ[NO2-]/NO3- dose, change in
plasma [NO2-] relative to dose of NO3- ingested per kg body mass; SFR-Q,
salivary ﬂow rate questionnaire.
* Diﬀerent from old, P < 0.05.
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(2× 70ml d−1, each 70ml containing ~ 6.2mmol NO3-; Beet It, James
White Drinks, Ipswich, UK) and NO3- -depleted concentrated beetroot
juice placebo (PL) (2× 70ml d−1, each 70ml containing ~ 0.01mmol
NO3-; Beet It, James White Drinks, Ipswich, UK). The PL was indis-
tinguishable from the BR supplement in appearance, taste and smell.
Participants were instructed to consume one 70-ml beverage in the
morning and one in the afternoon. On testing days, participants were
asked to ingest one 70-ml beverage in the morning and one 2.5 h prior
to their laboratory visit. A washout period of at least three days and up
to 47 days (18±14 days) separated the supplementation periods.
Participants were instructed to maintain their normal daily activities,
food intake and oral hygiene regime throughout the study. However,
participants were instructed to refrain from using antibacterial
mouthwash during the study period. Participants were advised that
supplementation may cause beeturia (red urine) and red stools tem-
porarily, but that such side eﬀects were harmless.
2.5. Oral bacteria
Oral swabs of the tongue dorsum were collected at baseline. Saliva
samples (~ 1ml) were collected by expectoration, without stimulation,
over a period of 5min on three occasions following PL and BR sup-
plementation periods. Oral swab and saliva samples were stored at
− 80 °C until analysis. Genomic DNA was isolated from tongue swabs
using a Gentra Puregene Buccal Cell Kit (Qiagen, Germantown, MD),
and from saliva samples following the methods of Goode et al. [13].
Double-stranded DNA concentration was ﬂuorometrically quantiﬁed
(Qubit 3.0 high-sensitivity ﬂuorescence detection, ThermoFisher Sci-
entiﬁc, Waltham, MA). Library preparation employed a NEXTﬂex 16 S
V1-V3 Amplicon-Seq Kit (Bioo Scientiﬁc, Austin, USA). The 16 S V1-V3
rDNA region was ampliﬁed using 5 ng of dsDNA and subjected to 8
thermal cycles of 30 s at 98°, 30 s at 60° and 30 s at 72° with primers A
and B (Table S1). Following AMPure® XP bead cleanup (Becton Dick-
inson, Franklin Lakes, NJ), a subsequent PCR with indexing primers to
identify individual samples, containing Illumina ﬂow cell binding sites,
was performed.
The samples were sequenced using paired-end 300 base pair (bp)
MiSeq Illumina platform (Illumina, San Diego, CA) using v3 MiSeq re-
agents. For each sample, the nucleotide sequence data in FASTQ format
was trimmed using Trim-Galore! (Krueger F. Trim-Galore!, accessible at
http://www.bioinformatics.babraham.ac.uk/projects/trim_galore/).
Quality trimming was performed by removing low-quality bases from
the 3’ read ends. The adapter sequences were subsequently removed
from the 3’ end (the ﬁrst 13 base pairs). Trim-Galore! paired-end vali-
dation was performed to remove short sequences once the trimming
was complete, where the minimum speciﬁed length was 20 bp. The
bacterial taxonomies and abundance were assigned using Kraken
standard build, which uses the genomes in Refseq and NCBI taxonomic
information (Kraken manual, accessible at: http://ccb.jhu.edu/
software/kraken/MANUAL.html#kraken-databases). The paired read
sequences were classiﬁed and processed by the Kraken Taxonomic
Sequence Classiﬁcation System [41]. Variations in the V1-V3 regions
enabled NCBI taxonomic identiﬁcation, and kraken-translate was used
to translate the NCBI Identiﬁers to taxonomy identiﬁers. A Kraken re-
port was generated for each sample, which was visualised using Krona
bioinformatics pie charts [32].
2.6. Plasma [NO3-] and [NO2-]
Blood samples for determination of plasma [NO2-] and [NO3-] were
collected from an antecubital vein into lithium heparin tubes and
centrifuged for 8min at 3000g and 4 °C within 2min of collection.
Plasma was extracted and samples stored at − 80 °C for later determi-
nation of [NO3-] and [NO2-] using a modiﬁed chemiluminescence
technique as previously described [23].
2.7. Blood pressure and arterial stiﬀness
Blood pressure of the brachial artery was measured following
10min of seated rest in a quiet room using an automated sphygmo-
manometer (Dinamap Pro, GE Medical Systems, Tampa, USA). A total
of four measurements were taken, with the mean of the ﬁnal three
measurements recorded. The mean of the systolic (SBP), diastolic (DBP)
and mean arterial pressure (MAP) measurements made over three la-
boratory visits in each condition were calculated for each individual
and used for subsequent analyses. Arterial stiﬀness was estimated via
pulse-wave velocity (PWV) (Complior SP; Alam Medical, Vincennes,
Paris, France). Electrodes were placed on the carotid, femoral, and ra-
dial arteries, and the pulse transit time was calculated and recorded. A
mean of three measurements was calculated and used for subsequent
analyses. The position of each electrode was measured in relation to the
nearest bony landmark to enable precise reproduction of the position of
the electrodes in each condition.
2.8. Statistical analyses
The Kraken raw data output of phylogenetic data were analysed
using R-script (R Development Core Team 2008), SPSS V20 and
Microsoft Excel. Non-metric multidimensional scaling (NMDS) was
used to assess the level of microbiome similarity between young and
old, and PL and BR conditions using non-parametric relationships, and
analysed using ADONIS (Vegan R Software). Diﬀerences between PL
and BR conditions were assessed using paired t-tests with Bonferroni-
Hoechberg correction on bacteria that made up> 0.01% of bacteria (R
statistical software). The Shannon-Wiener diversity index (H’) was used
to explore diﬀerences in diversity (Vegan R Software). Paired-samples t-
tests were used to assess diﬀerences between BR and PL conditions in
plasma [NO2-] and [NO3-], BP and arterial stiﬀness. Relationships be-
tween plasma NO biomarkers, oral microbiome and physiological re-
sponses to supplementation were assessed using Pearson's correlation
coeﬃcients. Statistical signiﬁcance was accepted when P < 0.05 and
statistical trend was deﬁned as P < 0.10. Data were expressed as
mean± SD.
3. Results
The young and old participants were similar in terms of body mass
and BMI (Table 1). The young participants had a greater mean score in
SFR-Q than the old participants (Table 1), indicative of more frequent
self-reported symptoms of low salivary ﬂow rate. The young
Fig. 1. Participants underwent 10-day supplementation
periods with nitrate (~ 12.4 mmol/d) and placebo in a
balanced cross-over design. Screening, protocol familiar-
isation and Salivary Flow Rate Questionnaires (SFR-Q)
were completed at baseline. Measurements of plasma ni-
trite (NO2-) and nitrate (NO3-) concentrations, blood
pressure (BP) of the brachial artery, arterial stiﬀness as
carotid-femoral pulse wave velocity (PWV), and the col-
lection of saliva samples for microbiome analysis were
undertaken on days 8, 9 and 10 of each supplementation period.
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participants reported greater frequency of sensations associated with
dry mouth (old 1.6 ± 1.0, young 2.7 ± 0.5; P < 0.05) and having
diﬃculty eating dry foods (old 1.1 ± 0.3, young 1.8 ± 0.4;
P < 0.05).
3.1. NO biomarkers, blood pressure and arterial stiﬀness
The NO3- dose relative to body mass was not diﬀerent between
young and old participants, but the latter had a greater increase in
plasma [NO2-] in response to BR supplementation (Table 1). Plasma
[NO3-] and [NO2-] were signiﬁcantly higher following BR supple-
mentation compared with PL (all P < 0.05; Fig. 2, panels A and B). BR
supplementation increased plasma [NO3-] relative to PL by a similar
amount in old (1509 ± 744%) and young participants
(1481 ± 909%) (Fig. 2C), but the increase in [NO2-] was greater in old
(648 ± 477%) compared to young participants (365 ± 249%,
P < 0.05; Fig. 2D). There were no diﬀerences between young and old
participants in plasma [NO3-] in PL (old: 28 ± 12 μM, young:
28 ± 14 μM; P > 0.05) or BR conditions (old: 379 ± 55 μM, young:
366 ± 101 μM; P > 0.05). Plasma [NO2-] tended to be greater in the
old in PL (old: 173 ± 97 nM, young: 104 ± 63 nM; P=0.09) and was
signiﬁcantly greater in the old than young participants in the BR con-
dition (old: 1029 ± 393 nM, young: 380 ± 175 nM; P < 0.05).
MAP, SPB, DBP and PWV were not diﬀerent between PL and BR
conditions across all participants (n=18, P > 0.05; Fig. 3, panels A,
D, G and J). In old participants (n=9), SBP and MAP were signiﬁcantly
lower following BR supplementation compared with PL (Fig. 3, panels B
and E). Changes between PL and BR (Δ) in MAP, SBP, and DBP between
PL and BR conditions inversely correlated with the change in plasma
[NO2-] relative to NO3- dose per kg body mass (Δ[NO2-]/NO3 dose;
Fig. 3, panels C, F and I). BR supplementation did not signiﬁcantly alter
radial-femoral PWV (Fig. 3, panels J and K) across all participants, but
ΔPWV between BR and PL in the old participants (increase of
4.3 ± 10.9 m s−1; n= 9) was diﬀerent (P < 0.05) from ΔPWV in the
young participants (decrease of −6.8 ± 9.8m s−1; n= 9). ΔPWV po-
sitively correlated with Δ[NO2-]/NO3 dose (Fig. 3L). Absolute plasma
[NO2-] or [NO3-] measured in the PL condition were not correlated with
Δ[NO2-], ΔDBP, ΔSBP, ΔMAP or Δ PWV. One old male participant did
not wish to undertake PWV measurement and therefore all PWV data
are derived from 17 participants.
3.2. Tongue microbiome at baseline
Relative abundances of the ﬁve main oral bacterial phyla in tongue
swab samples collected at baseline were Bacteroidetes 32 ± 9%,
Fusobacteriales 27 ± 11%, Proteobacteria 20 ± 7%, Firmicutes
17 ± 5% and Actinobacteria 1 ± 1%. The most abundant bacterial
species found on the tongue were Fusobacterium nucleatum subsp. nu-
cleatum (16 ± 8%), Prevotella melaninogenica (14 ± 7%),
Campylobacter concisus (13 ± 8%), Leptorichia buccalis, (7 ± 6%)
Veillonella parvula (5 ± 3%), Prevotella intermedia (4 ± 2%),
Fusobacterium nucleatum subsp. vincentii (3 ± 3%) and Neisseria me-
ningitidis (3 ± 3%). Correlations between relative abundances of se-
lected taxonomic units of tongue bacteria and physiological responses
to BR supplementation are shown in Table 2. The greatest decreases in
BP were associated with high abundances at baseline of Fusobacterium
nucleatum subsp. vincentii and nucleatum, and order Actinomycetales,
whereas a high relative abundance of Prevotella melaninogenica was
associated with a greater mean score in SFR-Q, and smaller changes in
plasma [NO2-], SBP and PWV in response to BR supplementation
(Table 2).
3.3. Saliva microbiome after PL and BR supplementation
Relative abundances of the main phyla of oral bacteria diﬀered
between PL and BR conditions (Fig. 4). Relative abundance of Proteo-
bacteria was greater and Bacteroidetes was lower following BR com-
pared with PL (P < 0.05), while abundances of Firmicutes and
Fig. 2. Plasma [NO3-] (panel A) and [NO2-] (panel B) were
signiﬁcantly greater after nitrate supplementation (white
bars) compared to placebo (black bars) (n= 18). The
change (Δ) in plasma [NO3-] between nitrate and placebo
conditions was similar in young (n=9) and old partici-
pants (n= 9) (panel C), but Δ[NO2-] was signiﬁcantly
greater in the old compared to young participants (panel
D). Error bars indicate standard deviations and black
squares (panels C and D) indicate means for young and old
participants. *P < 0.05.
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Fusobacteria tended to be lower following BR supplementation com-
pared with PL (P < 0.10). NMDS plots revealed that oral microbial
communities diﬀered signiﬁcantly between PL and BR supplemented
conditions (Fig. 5A), but there were no diﬀerences between young and
old participants (Fig. 5B). A Shannon diversity index revealed no sig-
niﬁcant diﬀerences in species diversity between PL and BR conditions
(Fig. 6). Overall, 52 taxonomic units were signiﬁcantly diﬀerent be-
tween BR and PL conditions. Fig. 7 illustrates statistically signiﬁcant
diﬀerences at genera and species levels between PL and BR. The trend
for reduction in the relative abundance of Firmicutes following BR was
primarily due to a decrease in Veillonella (− 65%), including a 65%
decrease in Veillonella parvula species (both P < 0.05), while the order
Lactobacilliales and genus Streptococcus were not aﬀected by BR
(P > 0.05). Within the phylum Bacteroidetes, BR resulted in a reduc-
tion in the genus Prevotella (− 60%), and speciﬁcally P. melaninogenica
(− 67%) compared to PL (both P < 0.05). The increase in Proteo-
bacteria after BR stemmed from an increase in the order Neisseriales
(+348%), containing the genus Neisseria (+351%) and N. meningitidis
(+439%) (all P < 0.05), while there were no statistically signiﬁcant
changes in the genera Campylobacter or Haemophilus. Proportions of the
Fig. 3. Mean arterial pressure (MAP; panel A), systolic blood pressure (SBP; panel D), diastolic blood pressure (DBP; panel G) and pulse wave velocity (PWV; panel J)
were not diﬀerent between placebo and nitrate conditions across all participants (n= 18). The old participants (n=9) showed greater reductions (Δ) in MAP, SBP
and DBP between placebo and nitrate conditions than the young participants (n=9; panels B, E and H), as well as a greater increase in PWV (young n= 9, old n= 8;
panel K). ΔMAP, ΔSBP and ΔDBP inversely correlated with the change in plasma [NO2-] relative to nitrate dose (Δ[NO2-]/NO3- dose) (panels C, F and I) and ΔPWV
positively correlated with Δ[NO2-]/NO3- dose (panel L). *P < 0.05.
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phylum Actinobacteria were not signiﬁcantly diﬀerent between PL and
BR, but there was an increase in the genus Rothia (+127%, P < 0.05)
and R. mucilaginosa (+234%, P < 0.05) after BR supplementation re-
lative to PL. There was insuﬃcient microbial DNA in a saliva sample of
one young male participant and therefore the saliva microbiome data
were for 17 participants.
Correlations across PL and BR conditions showed that plasma
[NO3-] and [NO2-] positively correlated with relative abundances of
Rothia and Neisseria and inversely correlated with Prevotella and
Veillonella (Table 3). PWV positively correlated with relative abundance
of Rothia and R. mucilaginosa (Table 3).
4. Discussion
We used an in vivo experimental model and bacterial 16S rRNA gene
sequencing to examine relationships between the oral microbiome and
physiological indices of NO bioavailability in humans and changes in
these variables following NO3- supplementation. The principal ﬁnding
of this study was that dietary NO3- supplementation altered the salivary
microbiome in young (~ 20 yrs) and old (~ 74 yrs) normotensive hu-
mans, such that it increased relative abundances of some bacteria
capable of NO3-reduction (Rothia and Neisseria) while reducing the
abundances of other NO3- reducers (Prevotella and Veillonella). NO3-
supplementation increased NO bioavailability in all participants, as
indicated by plasma concentrations of NO3- and NO2-, and reduced
systemic blood pressure in the old, but not young, participants. Across
placebo and NO3- supplemented conditions, high abundances of Rothia
and Neisseria and low abundances of Prevotella and Veillonella were
associated with high NO bioavailability. The current ﬁndings indicate
that the oral microbial community was malleable to change with in-
creased dietary intake of inorganic NO3-, and, importantly, that the oral
microbiome was related to indices of NO homeostasis and vascular
health in vivo.
4.1. Relationships between the tongue microbiome at baseline and
responsiveness to NO3- supplementation
It has been proposed that the oral microbiome modulates the
magnitude of plasma [NO2-] increase, as well as changes in associated
physiological indices, in response to NO3- supplementa-
tion [6,17,18,25]. A recent study indicated that a composite relative
abundance of seven species (including Prevotella melaninogenica, Veil-
lonella parvula, and Rothia mucilaginosa) was positively correlated with
the rise in salivary [NO2-], but not plasma [NO2-], in response to acute
ingestion of a single NO3- bolus [7]. We found that individuals who had
high proportions of P. melaninogenica and Campylobacter concisus at
Table 2
Correlation coeﬃcients for relationships between selected taxonomic units of the tongue microbiome (% of total bacteria) at baseline and subsequent changes
between placebo and NO3- supplementation in plasma [NO2-], blood pressure and arterial stiﬀness. PWV data were not available for one old male participant, such
that ΔPWV correlations are for n=17.
Δ[NO2-]/NO3- dose (nM/mmol/
kg/D)
ΔDBP (mmHg) ΔSBP (mmHg) ΔMAP (mmHg) ΔPWV (m/s) SFR-Q mean
score
Δ[NO2-]/NO3- dose − 0.57* − 0.73** − 0.65** 0.65** − 0.52*
Actinobacteria Actinomycetales (order) 0.40 − 0.39 − 0.46# − 0.46# 0.47# − 0.004
Micrococcales (order) − 0.41 0.25 0.36 0.40 − 0.21 − 0.04
Rothia (genus) − 0.20 0.10 0.32 0.37 − 0.07 0.20
Rothia mucilaginosa − 0.22 0.17 0.38 0.44# − 0.08 0.18
Proteobacteria Neisseria (genus) 0.21 − 0.06 0.06 0.29 0.59* − 0.39
Neisseria meningitidis − 0.09 − 0.08 0.044 0.36 0.13 − 0.19
Campylobacter concisus − 0.55* 0.43# 0.65** 0.34 − 0.62** 0.30
Bacteroidetes Prevotella (genus) − 0.49* 0.19 0.43# 0.41# − 0.52* 0.51*
Prevotella melaninogenica − 0.57* 0.16 0.53* 0.37 − 0.68** 0.49*
Firmicutes Veillonella (genus) − 0.22 0.22 0.35 0.09 − 0.02 0.46#
Veillonella parvula − 0.19 0.22 0.35 0.10 0.02 0.41#
Fusobacteria Fusobacterium nucleatum subsp.
nucleatum
0.44# − 0.17 − 0.56* − 0.30 0.32 − 0.29
Fusobacterium nucleatum subsp.
vincentii
0.55* − 0.43# − 0.60** − 0.63** 0.45# − 0.36
Δ=change between placebo and NO3-; [NO2-]/NO3- dose =plasma [nitrite] relative to nitrate dose per kg body mass ingested; DBP=diastolic blood pressure;
SBP= systolic blood pressure; MAP=mean arterial pressure; PWV=pulse wave velocity; SFR-Q= salivary ﬂow rate questionnaire.
** P < 0.01.
* P < 0.05.
# P < 0.10.
Fig. 4. The proportions of ﬁve main phyla of oral bacteria identiﬁed in the saliva samples following 10 days of placebo (PL) and NO3- supplementation (BR).
*Diﬀerence between PL and BR (P < 0.05).
A. Vanhatalo et al. Free Radical Biology and Medicine 124 (2018) 21–30
26
baseline were less responsive to chronic NO3- supplementation, i.e. had
smaller increases in plasma [NO2-] and smaller or no reductions in BP,
than those individuals who had low abundances of P. melaninogenica
and C. concisus. In addition, a high mean SFR-Q score at baseline, which
indicated more frequent self-reported symptoms of dry mouth, was
associated with greater abundance of Prevotella and a smaller increase
in plasma [NO2-] in response to NO3- supplementation. Campylobacter
concisus is believed to express dissimilatory NO3- reduction to NH3 and
its main physiological function is NO2- reduction [36], while P. mela-
ninogenica has been shown to encode NO2-, but not NO3-, reductase
genes [18]. It may, therefore, be speculated that during subsequent
NO3- supplementation both C. concisus and P. melaninogenica, which
were dominant species in tongue swab samples at baseline, acted as net
consumers of NO2- in the oral cavity. In contrast, high abundances of
Fusobacterium nucleatum subspecies and Actinomycetales at baseline
were associated with greater increases in plasma [NO2-] and greater
reductions in blood pressure in response to NO3- supplementation
(Table 2). Actinomycetales are generally obligate anaerobes, and in-
cludes several species such as Actinomyces odontolyticus and Actinomyces
naeslundii that have been identiﬁed as eﬀective NO3- reducers [10].
Fusobacterium nucleatum can reduce NO2-, but does not possess NO3--
reductase genes. However, F. nucleatum provides ‘scaﬀolding’ in bio-
ﬁlms, enabling microbial attachments [26], and it is possible that these
bacteria may have facilitated attachment and proliferation of key NO3-
reducing bacteria during dietary intervention.
4.2. Changes in the salivary microbiome after NO3- supplementation
We showed that, relative to placebo, NO3- supplementation altered
the proportions of the main oral microbial phyla by decreasing the
Bacteroidetes and increasing the Proteobacteria. At the genus level,
NO3- supplementation signiﬁcantly increased relative abundances of
the previously identiﬁed NO3- reducers Neisseria [18] and Rothia [10] in
saliva. This was consistent with a report of a signiﬁcant increase in N.
ﬂavescens and a trend for an increase in R. mucilaginosa in saliva sam-
ples of hypercholesterolaemic patients after 6 weeks of NO3- supple-
mentation [39]. A novel ﬁnding in the present study was that a high
abundance of the facultative anaerobe R. mucilaginosa was associated
with faster pulse wave velocity, indicative of lower arterial stiﬀness.
These data suggest that high relative abundances of bacteria belonging
to Neisseria and Rothia were related to high NO bioavailability and may
promote vascular health.
We also found that compared to placebo, NO3- supplementation
decreased relative abundances of the obligate anaerobic bacteria
Prevotella and Veillonella in saliva. This ﬁnding appears to contradict
studies that have used in vitro approaches to identify key oral NO3-
reducing taxa. Hyde et al. [18] categorised bioﬁlms prepared from
tongue swab samples of six healthy humans as best, intermediate and
worst NO3- reducers and found greater abundances of both Prevotella
and Veillonella in the best versus worst NO3- reducing bioﬁlms. Using
tongue swab samples from ten healthy humans, which were incubated
on solid medium under aerobic and anaerobic conditions and analysed
by 16 S rDNA sequencing, Doel et al. [10] concluded that Veillonella
were the most prevalent oral NO3- reducers and were major con-
tributors to net NO2- production. Intricate metabolic interactions
among the oral microbiota might mean that increased NO3- availability
in the oral cavity may not facilitate the growth of all bacteria capable of
NO3- reduction. It is not directly apparent why NO3- supplementation
resulted in a decline in Veillonella. One factor that may have contributed
to proliferation of some taxa and inhibition of others is the oral pH,
which is a powerful modulator of the oral microbial community.
Beetroot juice supplementation has been shown to increase oral pH
from 7.0 to 7.5 [15], and notably, a pH of 8 is optimal for NO3- re-
ductase activity [38]. Monitoring of salivary pH alongside alterations in
the oral microbiome during NO3- supplementation should be under-
taken in future studies to address the possible eﬀects of pH.
Given that many oral bacteria with ability to reduce NO3- are also
capable of downstream metabolism of the produced NO2-, it is im-
portant to diﬀerentiate between NO3-reducing bacteria in general and
NO2- accumulating bacteria speciﬁcally. NO3- reducing oral bacteria
have been identiﬁed in vitro from human samples, including Veillonella,
Actinomyces, Rothia, Staphylococcus and Propionibacterium [10]. More
recently Hyde et al. [18] added Neisseria, Haemophilus parainﬂuenzae,
Prevotalla (including P. melaninogenica) and Granulicatella to the list of
candidate species for most potent contributors to oral NO2- production.
We showed that some of the oral bacteria that have been proposed as
key NO2- accumulators on the basis of in vitro experiments, such as
Veillonella and Prevotella, do not thrive under high NO3- availability in
vivo. Indeed, we found no signiﬁcant changes in relative abundances of
Actinomyces, Staphylococcus, Propionibacterium, Granulicatella or Hae-
mophilus after NO3- supplementation. In order to contribute sig-
niﬁcantly to the amount of NO2- that is swallowed from the oral cavity,
Fig. 5. Overall salivary microbiome composition illustrated by non-metric
multidimensional scaling (NMDS) analysis. The salivary microbiome composi-
tion was diﬀerent between nitrate (BR) and placebo (PL) conditions (P < 0.05;
panel A) but not between young and old participants (P > 0.05; panel B).
Fig. 6. The Shannon diversity index indicated no statistically signiﬁcant dif-
ference in species diversity between nitrate (BR) and placebo (PL) conditions.
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the bacteria need to reduce NO3- at a faster rate than they reduce NO2-,
or not undertake downstream metabolism of NO2- at all. Overall, to
maximise NO bioavailability from a NO3- -rich diet, the composition of
the oral microbial community needs to be such that it contains a greater
quantity of net NO2- accumulators than net NO2- consumers. Further
research is needed to establish whether the observed microbiome
changes following chronic NO3- supplementation in the present cohort,
are replicated in diﬀerent populations and whether such changes are
associated with an increased capacity for acute NO3- reduction in the
oral cavity.
The present data suggest that the chronic (10-day) NO3- supple-
mentation serves to change the relative abundance of a few, but not all,
NO3- reducing taxa and that these changes are correlated with bene-
ﬁcial changes in NO bioavailability and indices of cardiovascular
Fig. 7. The genera (panels A and B) and species (panels C and D) that comprised> 0.01% of all bacteria and showed signiﬁcant diﬀerences (P < 0.05) between
nitrate (BR) and placebo (PL) conditions.
Table 3
Correlation coeﬃcients (r) for relationships between relative abundances of selected taxonomic units of saliva microbiome (% of total bacteria) and plasma nitrate
([NO3-]) and nitrite ([NO2-]); diastolic (DBP), systolic (SBP) and mean arterial (MAP) blood pressure; and pulse wave velocity (PWV) across placebo and nitrate
conditions. Microbiome data were not available for one young male subject and PWV data were not available for one older male subject, such that [NO3-], [NO2-] and
BP correlations are for n= 34 and PWV correlations are for n= 32.
[NO3-] (μM) [NO2-] (nM) DBP (mmHg) SBP (mmHg) MAP (mmHg) PWV (m/s)
Actinobacteria Actinomycetales (order) 0.25 0.09 − 0.01 − 0.09 − 0.05 0.06
Micrococcales (order) 0.37* 0.23 − 0.03 0.02 0.00 0.48**
Rothia (genus) 0.45** 0.30# 0.04 0.03 0.04 0.45*
Rothia mucilaginosa 0.46** 0.37* 0.06 − 0.03 − 0.01 0.41*
Proteobacteria Neisseria (genus) 0.61** 0.64** 0.02 0.15 0.14 − 0.13
Neisseria meningitidis 0.54** 0.53** − 0.00 0.07 0.08 − 0.23
Campylobacter concisus − 0.26 − 0.17 − 0.17 0.08 0.02 0.42*
Bacteroi-detes Prevotella (genus) − 0.47** − 0.35* 0.11 0.21 0.18 − 0.18
Prevotella melaninogenica − 0.47** − 0.35* 0.06 0.17 0.12 − 0.09
Firmicutes Veillonella (genus) − 0.62** − 0.50** − 0.10 − 0.01 − 0.22 − 0.07
Veillonella parvula − 0.60** − 0.49** − 0.10 − 0.03 − 0.23 − 0.08
Fuso-bacteria Fusobacterium nucleatum subsp. nucleatum − 0.28 − 0.18 0.00 0.08 0.05 − 0.10
Fusobacterium nucleatum subsp. vincentii − 0.16 − 0.01 − 0.03 0.12 0.07 − 0.17
DBP=diastolic blood pressure; SBP= systolic blood pressure; MAP=mean arterial pressure; PWV=pulse wave velocity.
** P < 0.01.
* P < 0.05.
# P < 0.10.
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health. It should be noted that elevated NO bioavailability may have
further beneﬁcial eﬀects on aspects of healthy ageing, including
maintenance of a strong immune response. A recent study showed that
tongue microbiomes that had high abundances of Prevotella and
Veillonella species were associated with elevated risks of all-cause
mortality and mortality from pneumonia in frail elderly nursing home
residents [21]. NO3- supplementation in older people, which reduces
the relative abundances of Prevotella and Veillonella, may therefore have
potential to enhance the NO-mediated immune response in this high-
risk population.
4.3. Diﬀerences in [NO2-] and blood pressure responses between young and
old participants
Previous studies have shown appreciable inter-individual variability
in the plasma [NO2-] and blood pressure responses to NO3- ingestion in
both young and older populations (e.g. [8,19,23]). We found that de-
spite ingesting the same dose of NO3- the old adults showed a greater
plasma [NO2-] increase than the young adults, and also exhibited a
reduction in blood pressure which was absent in the young participants.
The magnitude of the BP response to NO3-supplementation is correlated
with baseline blood pressure [22,40], such that in the present study the
scope for a BP decrease in the young adults, who had a BP of ~ 112/
63mmHg in placebo, was likely small. Although the balance of evi-
dence indicates that NO3- represents an potent dietary means for re-
ducing systemic BP [22,25,27,40,6], it is important to note that there
are several studies that concur with the present ﬁnding of not showing a
signiﬁcant change in resting systolic or diastolic BP (or both) in young,
healthy adults (e.g. [24,28,31,37]).
Since the human vascular response to NO3- supplementation is de-
pendent on eﬃcient bacterial reduction of NO3- to NO2-, it is possible
that at least some of this variability is linked to diﬀerences between
individuals in the oral microbiota and therefore oral NO3- reducing
capacity. NMDS analysis revealed no overall diﬀerences in the salivary
microbiomes between young and old participants, or following placebo
or NO3- supplementation. The greater responsiveness to supplementa-
tion in the old compared to young participants was surprising, given
that ageing is typically associated with reduced salivary ﬂow rate and
altered oral bacterial colonisation [33]. It is important to note that al-
though the self-reported frequency of dry mouth symptoms was greater
in the young adults, we did not directly quantify salivary ﬂow rate in
this study, and agreement between self-reported xerostomia ques-
tionnaire data and measured saliva secretion rate varies [11,29,30]. We
are therefore unable to determine whether the higher occurrence of
self-reported symptoms of dry mouth in the young adults was in fact
attributed to signiﬁcantly lower salivary ﬂow in comparison to the old
adults. Whether possible diﬀerences in salivary ﬂow rate and/or NO3-
uptake into the enterosalivary circulation via sialin 2NO3-/H+ trans-
porters [34] contribute to inter-individual variability in responsiveness
to NO3- supplementation irrespective of age warrants further in-
vestigation with large cross-sectional cohorts across the human life-
span.
Physical exercise and diet are emerging as powerful modulators of
the gut microbiota [1] and it is intuitive that the microbiota in the oral
cavity, the uppermost section of the alimentary canal, may also vary
according to age, diet, and with physical activity levels. There is evi-
dence to suggest that the gut microbiome of healthy older people may
be remarkably similar to that of young adults [4], and that age-related
alterations in the gut microbiome may be related to advancing frailty
and development of disease [3]. Whether the maintenance of a ‘young’
gut microbiome into older age is a cause or consequence of healthy
ageing is unknown. Our data suggest that the oral microbiome of in-
dividuals who have reached their 8th decade of life without chronic
disease is indistinguishable from oral microbiome of young adults. The
inclusion criteria in the present study meant that the enrolled old
participants were in exceptionally good health for their age and
therefore not representative of an ageing population with poor cardi-
ovascular and/or metabolic health, who may be less responsive to NO3-
supplementation due to impairments in NO bioactivity [35]. Indeed, we
found that there was no diﬀerence in blood pressure between young
and old participants following NO3- supplementation. Longitudinal
studies are necessary to identify possible changes that may occur in the
oral microbiome, and NO bioavailability, at the onset of chronic dis-
ease.
The dietary interventions in the present study consisted of twice
daily ingestion of NO3--rich and NO3--depleted beetroot juice con-
centrate that were matched for carbohydrate and polyphenol content
[12]. It should be noted that the alterations we observed in the salivary
microbiome following NO3--rich beetroot juice supplementation may be
due to NO3- alone or an additive eﬀect of NO3- and other nutritional
components of the beetroot supplement. Elevated carbohydrate intake
may have favoured the growth of those microbes that use carbohydrate
as an energy substrate at the expense of proteolytic bacteria, such as
Prevotella. Further studies using supplementation with salts of NO3-
(KNO3, NaNO3) are warranted to ascertain the eﬀect of NO3- alone on
the oral microbiome.
4.4. Methodological considerations
Microbial analysis was performed on tongue swab samples at
baseline and on saliva samples following placebo and NO3- supple-
mentation periods. Saliva samples represent a composite of bacteria
from all oral sites, while tongue swab samples target the tongue dorsum
which was shown to have the highest NO3- reductase activity by Doel
et al. [10]. The quantities and relative abundances of bacteria vary
between diﬀerent oral sites, such that potential changes in microbiome
assessed from tongue swabs following NO3- supplementation may diﬀer
from those observed in the saliva samples in the present study. How-
ever, given the similarities of ﬁndings on Neisseria and Rothia between
the present study and that of Velmurugan et al. [39], we are conﬁdent
that the salivary microbiome analyses in the present study captured
representative and meaningful diﬀerences between conditions in the
NO3- reducing oral microbiome. A limitation of the current study was
that saliva samples could not be included at the beginning of each
supplementation period, and the wash-out period required for NO3-
-induced changes in the oral microbiome to return to baseline following
cessation of supplementation is not known. Future work should include
in vivo tests of oral NO3- reduction capacity to ascertain whether the
changes in oral microbiome following chronic NO3- supplementation
are associated with enhanced oral NO3- reduction. In the present study,
we inferred enhanced oral NO3- reduction from plasma [NO2-]. Finally,
further investigation should target the optimisation of the dose and
duration of prebiotic NO3- supplementation, and its possible interac-
tions with the macronutrient content of the diet, to provide maximal
functional eﬀects of NO3- supplementation.
4.5. Conclusions
Imbalances in the oral microbial community and poor dental health
have been associated with reduced cardiovascular and metabolic
health. We showed that ageing, per se, in the absence of chronic disease,
does not impair an individual's ability to reduce dietary NO3- and in-
crease plasma [NO2-] in response to NO3- supplementation. Using 16S
rRNA gene sequencing of oral bacteria in an in vivo experimental model,
we showed that high abundances of oral bacteria belonging to genera
Prevotella and Veillonella were likely detrimental, while high abun-
dances of the genera Rothia and Neisseria were likely beneﬁcial for the
maintenance of NO homeostasis and associated indices of cardiovas-
cular health. The symbiotic relationship between the oral microbiome
and its human host is a fast evolving ﬁeld of research with signiﬁcant
implications for development of prebiotic and probiotic interventions to
improve cardiovascular and metabolic health. Our results identify
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dietary NO3- as a modulator of the oral NO2--producing microbiome in
healthy humans and highlight the potential of oral microbiota-targeted
therapies for ameliorating conditions related to low NO bioavailability.
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